Ireland

--:--IST

Latest

Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide

Subscribe

Registers› Irish medicines ›Eli Lilly Nederland B.V.

Medicines register · Ireland

Eli Lilly Nederland B.V. — licensed medicines

99 medicines held by Eli Lilly Nederland B.V. on the Irish market, from the HPRA register.

Source: HPRA open dataset ("Authorised or Transfer Pending Products"), CC BY 4.0. Complete coverage — all 10,336 authorised products are in this register. Synced 20 Sep 2026, 17:51 UTC

Narrow the register Reset

Search within results

Matches brand name, active substance, licence holder and licence number.

Browse by first letter

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9

Medicine

Active substance

Licence holder

Status

Mounjaro 12.5 mg solution for injection in pre-filled pen EU/1/22/1685/013-015

Tirzepatide

Eli Lilly Nederland B.V.

—

Mounjaro 12.5 mg/dose KwikPen solution for injection in pre-filled pen EU/1/22/1685/057-058

Tirzepatide

Eli Lilly Nederland B.V.

—

Mounjaro 15 mg solution for injection in pre-filled pen EU/1/22/1685/016-018

Tirzepatide

Eli Lilly Nederland B.V.

—

Mounjaro 15 mg/dose KwikPen solution for injection in pre-filled pen EU/1/22/1685/059-060

Tirzepatide

Eli Lilly Nederland B.V.

—

Mounjaro 2.5 mg solution for injection in pre-filled pen EU/1/22/1685/001-003

Tirzepatide

Eli Lilly Nederland B.V.

—

Mounjaro 2.5 mg/dose KwikPen solution for injection in pre-filled pen EU/1/22/1685/049-050

Tirzepatide

Eli Lilly Nederland B.V.

—

Mounjaro 5 mg solution for injection in pre-filled pen EU/1/22/1685/004-006

Tirzepatide

Eli Lilly Nederland B.V.

—

Mounjaro 5 mg/dose KwikPen solution for injection in pre-filled pen EU/1/22/1685/051-052

Tirzepatide

Eli Lilly Nederland B.V.

—

Mounjaro 7.5 mg solution for injection in pre-filled pen EU/1/22/1685/007-009

Tirzepatide

Eli Lilly Nederland B.V.

—

Mounjaro 7.5 mg/dose KwikPen solution for injection in pre-filled pen EU/1/22/1685/053-054

Tirzepatide

Eli Lilly Nederland B.V.

—

Olumiant 1 mg film-coated tablets EU/1/16/1170/017-019

Baricitinib

Eli Lilly Nederland B.V.

—

Olumiant 2 mg film-coated tablets EU/1/16/1170/001-008

Baricitinib

Eli Lilly Nederland B.V.

—

Olumiant 2 mg/mL oral suspension EU/1/16/1170/020-021

Baricitinib

Eli Lilly Nederland B.V.

—

Olumiant 4 mg film-coated tablets EU/1/16/1170/009-016

Baricitinib

Eli Lilly Nederland B.V.

—

Omvoh 100 mg solution for injection in pre-filled syringe EU/1/23/1736/002-003

MIRIKIZUMAB

Eli Lilly Nederland B.V.

—

Omvoh 100mg + 200mg solution for injection in pre-filled pen EU/1/23/1736/009-010

MIRIKIZUMAB

Eli Lilly Nederland B.V.

—

Omvoh 100mg +200mg solution for injection in pre-filled syringe EU/1/23/1736/007-008

MIRIKIZUMAB

Eli Lilly Nederland B.V.

—

Omvoh 100mg solution for injection in pre-filled pen EU/1/23/1736/004-006

MIRIKIZUMAB

Eli Lilly Nederland B.V.

—

Omvoh 300 mg concentrate for solution for infusion EU/1/23/1736/001

MIRIKIZUMAB

Eli Lilly Nederland B.V.

—

Optruma 60 mg film coated tablets EU/1/98/074/001

Raloxifene

Eli Lilly Nederland B.V.

—

Optruma 60 mg film coated tablets EU/1/98/074/002

Raloxifene

Eli Lilly Nederland B.V.

—

Optruma 60 mg film coated tablets EU/1/98/074/003

Raloxifene

Eli Lilly Nederland B.V.

—

Optruma 60 mg film coated tablets EU/1/98/074/004

Raloxifene

Eli Lilly Nederland B.V.

—

Pemetrexed Lilly EU/1/15/1034/001

Pemetrexed disodium heptahydrate

Eli Lilly Nederland B.V.

—

Pemetrexed Lilly EU/1/15/1034/002

Pemetrexed disodium heptahydrate

Eli Lilly Nederland B.V.

—

RAYVOW 100 mg film-coated tablets EU/1/21/1587/011-020

Lasmiditan Succinate

Eli Lilly Nederland B.V.

—

RAYVOW 200 mg film-coated tablets EU/1/21/1587/021-030

Lasmiditan Succinate

Eli Lilly Nederland B.V.

—

RAYVOW 50 mg film-coated tablets EU/1/21/1587/001-010

Lasmiditan Succinate

Eli Lilly Nederland B.V.

—

Retsevmo 120 mg film-coated tablets EU/1/20/1527/018-020

Selpercatinib

Eli Lilly Nederland B.V.

—

Retsevmo 160 mg film-coated tablets EU/1/20/1527/021-023

Selpercatinib

Eli Lilly Nederland B.V.

—

Retsevmo 40 mg film-coated tablets EU/1/20/1527/012-014

Selpercatinib

Eli Lilly Nederland B.V.

—

Retsevmo 40 mg hard capsules EU/1/20/1527/001

Selpercatinib

Eli Lilly Nederland B.V.

—

Retsevmo 80 mg film-coated tablets EU/1/20/1527/015-017

Selpercatinib

Eli Lilly Nederland B.V.

—

Retsevmo 80 mg hard capsules EU/1/20/1527/002-003

Selpercatinib

Eli Lilly Nederland B.V.

—

Strattera 4 mg/mL oral solution PA2276/007/008

ATOMOXETINE

Eli Lilly Nederland B.V.

Not marketed

Tadalafil Lilly 10 mg film-coated tablets EU/1/17/1177/005

Tadalafil

Eli Lilly Nederland B.V.

—

Tadalafil Lilly 2.5 mg film-coated tablets EU/1/17/1177/001

Tadalafil

Eli Lilly Nederland B.V.

—

Tadalafil Lilly 20 mg film-coated tablets EU/1/17/1177/006-009

Tadalafil

Eli Lilly Nederland B.V.

—

Tadalafil Lilly 5 mg film-coated tablets EU/1/17/1177/002-004

Tadalafil

Eli Lilly Nederland B.V.

—

Tauvid 800 MBq/mL solution for injection EU/1/24/1799/001

Flortaucipir (18F)

Eli Lilly Nederland B.V.

—

Trulicity 0.75 mg Solution for injection EU/1/14/956/001-005

Dulaglutide

Eli Lilly Nederland B.V.

—

Trulicity 1.5 mg Solution for injection EU/1/14/956/006-010

Dulaglutide

Eli Lilly Nederland B.V.

—

Trulicity 3 mg Solution for injection EU/1/14/956/011-0013

Dulaglutide

Eli Lilly Nederland B.V.

—

Trulicity 4.5 mg Solution for injection EU/1/14/956/014-0016

Dulaglutide

Eli Lilly Nederland B.V.

—

Verzenios 100 mg Film-coated tablet EU/1/18/1307/004-006

ABEMACICLIB

Eli Lilly Nederland B.V.

—

Verzenios 150 mg Film-coated tablet EU/1/18/1307/007-009

ABEMACICLIB

Eli Lilly Nederland B.V.

—

Verzenios 50 mg Film-coated tablet EU/1/18/1307/001-003

ABEMACICLIB

Eli Lilly Nederland B.V.

—

Yentreve EU/1/04/280/1-6

Duloxetine hydrochloride

Eli Lilly Nederland B.V.

—

Yentreve 20 mg hard gastro-resistant capsules EU/1/04/280/001

Duloxetine hydrochloride

Eli Lilly Nederland B.V.

—

Cite this view

Priya Life Science (2026). Irish Medicines Register, filtered. Derived from the HPRA open dataset. Retrieved 3 October 2026. https://priyalifescience.com/medicines/company/eli-lilly-nederland-b-v

Download this register

GET /api/export.php?register=medicines-ie&format=csv Try the JSON export →

Regulatory information only — not medical advice. For the authoritative record see the HPRA register directly.